Pharmagen Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Pharmagen recent Real Value cannot be determined due to lack of data. The prevailing price of Pharmagen is $0.0. Our model determines the value of Pharmagen from analyzing the company fundamentals such as Price To Earning of (0.06) X, current valuation of 5.93 M, and Return On Asset of -0.59 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Pharmagen's valuation include:
Undervalued
Today
Please note that Pharmagen's price fluctuation is out of control at this time. Calculation of the real value of Pharmagen is based on 3 months time horizon. Increasing Pharmagen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Pharmagen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Pharmagen Stock. However, Pharmagen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Pharmagen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Pharmagen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Pharmagen helps investors to forecast how Pharmagen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Pharmagen more accurately as focusing exclusively on Pharmagen's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Pharmagen's intrinsic value based on its ongoing forecasts of Pharmagen's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Pharmagen's closest peers.
Pharmagen Cash |
|
Pharmagen Valuation Drivers Correlation
Many accounts on the financial statements of Pharmagen are highly interrelated and sometimes correlated. Consequently, when conducting Pharmagen's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Pharmagen
Click cells to compare fundamentals
Pharmagen Valuation Trend
Analysing the historical paterns of Pharmagen's enterprise value and its market capitalization is a good way to estimate and gauge the value of Pharmagen over time and is usually enough for investors to make rational market timing decisions.
Pharmagen Total Value Analysis
Pharmagen is at this time projected to have valuation of 5.93 M with market capitalization of 361.95 K, debt of 2.16 M, and cash on hands of 264.67 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Pharmagen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.93 M | 361.95 K | 2.16 M | 264.67 K |
Pharmagen Investor Information
The company had not issued any dividends in recent years. Pharmagen had 45:1 split on the 7th of December 2011. Based on the analysis of Pharmagen's profitability, liquidity, and operating efficiency, Pharmagen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Pharmagen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Pharmagen has an asset utilization ratio of 375.34 percent. This suggests that the Company is making $3.75 for each dollar of assets. An increasing asset utilization means that Pharmagen is more efficient with each dollar of assets it utilizes for everyday operations.Pharmagen Profitability Analysis
The company reported the previous year's revenue of 4.81 M. Net Loss for the year was (6 M) with profit before overhead, payroll, taxes, and interest of 2.75 M.About Pharmagen Valuation
Our relative valuation model uses a comparative analysis of Pharmagen. We calculate exposure to Pharmagen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Pharmagen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.5 M | 3.7 M | |
| Pretax Profit Margin | (1.12) | (1.18) | |
| Operating Profit Margin | (0.40) | (0.42) | |
| Net Loss | (1.21) | (1.27) | |
| Gross Profit Margin | 0.57 | 0.50 |
Pharmagen Current Valuation Indicators
Valuation refers to the process of determining the present value of Pharmagen and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Pharmagen we look at many different elements of the entity such as Pharmagen's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Pharmagen, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Pharmagen's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Pharmagen's worth.Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.